Health-related quality-of-life tools in heart failure

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 5, Issue 3, 2005, Pages 267-270

  Asadi Lari, Mohsen ^a   Rao, Archana ^b   Gray, David ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Generic and specific tools; Health related quality of life; Heart failure; Minnesota Living with Heart Failure Questionnaire; The Kansas City Cardiomyopathy Questionnaire

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHRONIC DISEASE; CORRELATION ANALYSIS; DISEASE CONTROL; HEALTH CARE DELIVERY; HEALTH SURVEY; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SELF CONCEPT; SHORT FORM 36; SURVIVAL RATE;

EID: 21244478273     PISSN: 14737167     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737167.5.3.267     Document Type: Article

References (35)

1. Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine, Fifth Edition. Braunwald E (Ed.), Saunders, PA, USA (1997).
2. Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 358(9280), 439-444 (2001).
3. Hobbs FD. Unmet need for diagnosis of heart failure: the view from primary care. Heart 88(Suppl. 2), 9-11 (2002).
4. McDonagh TA, Morrison CE, Lawrence A et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350(9081), 829-833 (1997).
5. Cowie MR. BNP: soon to become a routine measure in the care of patients with heart failure? Heart 83(6), 617-618 (2000).
6. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J. Heart Lung Transplant 13(4), S107-S112 (1994).
7. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J. Am. Coll. Cardiol. 26(7), 1565-1574 (1995).
8. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J. Am. Coll. Cardiol. 33(7), 1948-1955 (1999).
9. Kitzman DW, Gardin JM, Gottdiener JS et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am. J. Cardiol. 87(4), 413-419 (2001).
10. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from 'diastolic heart failure' or from misdiagnosis? A prospective descriptive study. Br. Med. J. 321(7255), 215-218 (2000).
11. Banerjee P, Banerjee T, Khand A, Clark AL, Cleland JG. Diastolic heart failure:neglected or misdiagnosed? J. Am. Coll. Cardiol. 39, 138-141 (2002).
12. Cohn JN. Improving outcomes in congestive heart failure: Val-HeFT. Valsartan in Heart Failure Trial. Cardiology 91(Suppl. 1), 19-22 (1999).
13. Alla F, Briancon S, Guillemin F et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur. J. Heart Fail. 4(3), 337-343 (2002).
14. Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur. J. Heart Fail. 7(2), 243-251 (2005).
15. Oldridge N, Perkins A, Hodes Z. Comparison of three heart disease specific health-related quality of life instruments. Monaldi Arch. Chest Dis. 58(1), 10-18 (2002).
16. Streiner D, Norman G. Health Measurement Scales: a Practical Guide to Their Development and Use, Second Edition. Oxford University Press, Oxford, UK (1995).
17. Jaarsma T, Stromberg A, Martensson J, Dracup K. Development and testing of the European Heart Failure Self-Care Behaviour Scale. Eur. J. Heart Fail. 5(3), 363-370 (2003).
18. Arena R, Humphrey R, Peberdy MA. Using the Duke Activity Status Index in heart failure. J. Cardiopulm. Rehabil. 22, 93 (2002).
19. Steinhauser KE, Bosworth HB, Clipp EC et al. Initial assessment of a new instrument to measure quality of life at the end of life. J. Palliat. Med. 5(6), 829-841 (2002).
20. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am. Heart J. 124(4), 1017-1025 (1992).
21. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am. J. Cardiol. 71(12), 1106-1107 (1993).
22. Middel B, Bouma J, de Jongste M et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHFQ-Q). Clin. Rehabil. 15(5), 489-500 (2001).
23. Bennett SJ, Oldridge NB, Eckert GJ et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual. Life Res. 11(4), 349-359 (2002).
24. Bennett SJ, Oldridge NB, Eckert GJ et al. Comparison of quality of life measures in heart failure. Nurs. Res. 52(4), 207-216 (2003).
25. Riegel B, Moser DK, Glaser D et al. The Minnesota Living With Heart Failure Questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs. Res. 51(4), 209-218 (2002).
26. Hou N, Chui MA, Eckert GJ, Oldridge NB, Murray MD, Bennett SJ. Relationship of age and sex to health-related quality of life in patients with heart failure. Am. J. Crit. Care 13(2), 153-161 (2004).
27. Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J. Gen. Intern. Med. 4(2), 101-107 (1989).
28. Guyatt GH, Sullivan CM, Fallen EL. A controlled trial of digoxin in congestive heart failure. Am. J. Cardiol. 61, 371-375 (1988).
29. Wolinsky FD, Wyrwich KW, Nienaber NA, Tierney WM. Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval. Health Prof. 21(2), 216-243 (1998).
30. Guyatt GH. Measurement of health-related quality of life in heart failure. J. Am. Coll. Cardiol. 22(4 Suppl. A), 185A-191A (1993).
31. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J. Am. Coll. Cardiol. 35(5), 1245-1255 (2000).
32. Soto GE, Jones P, Weintraub WS, Krumholz HM, Spertus JA. Prognostic value of health status in patients with heart failure after acute myocardial infarction. Circulation 110(5), 546-551 (2004).
33. Hauptman PJ, Masoudi FA, Weintraub WS, Pina I, Jones PG, Spertus JA. Variability in the clinical status of patients with advanced heart failure. J. Card. Fail. 10(5), 397-402 (2004).
34. Clark DO, Tu W, Weiner M, Murray MD. Correlates of health-related quality of life among lower-income, urban adults with congestive heart failure. Heart Lung 32(6), 391-401 (2003).
35. Wiklund I, Lindvall K, Swedberg K, Zupkis RV. Self-assessment of quality of life in severe heart failure. An instrument for clinical use. Scand. J. Psychol. 28(3), 220-225 (1987).